Skip to main content

Month: June 2021

Trifork joins Fintech company as co-owner together with Arbejdernes Landsbank, Nykredit and Spar Nord

Press releaseSchindellegi – SwitzerlandTrifork has agreed with the existing owners of the Fintech company YoungMoney ApS to invest in the company and receive an ownership of 25% in the company. Young Money ApS is currently delivering the Young Money App universe to children in Denmark. Currently this App solution has approximately 40,000 users and just about 20,000 transactions are completed each month. The company plans to deliver innovative digital products and services to banks, both in Denmark and internationally. The products will be targeted to both private and business customers. “Joining Young Money as an owner is an example of Trifork’s philosophy about developing new products and solutions in very close relationship with our customers. Fintech is currently growing very fast and we want to continue developing new innovative...

Continue reading

Larimar Therapeutics to Present at the JMP Securities Life Sciences Conference

BALA CYNWYD, Pa., June 11, 2021 (GLOBE NEWSWIRE) — Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that Carole Ben-Maimon, MD, President and Chief Executive Officer of Larimar Therapeutics, will present and participate in virtual 1×1 investor meetings at the JMP Securities Life Sciences Conference taking place from June 16-17, 2021. See below for more details.Presentation Format: Fireside chatDate: June 16, 2021Time: 2:00 PM ETAbout Larimar Therapeutics Larimar Therapeutics, Inc. (Nasdaq: LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. Larimar’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program in...

Continue reading

Adyton reports silver potential with 2.7m @ 34 g/t Ag complementing recently reported high grade gold results

Figure 1Gameta Project drill hole plan. Refer Figure 2 for detailed view of Cross Section 25 showing Ag intersection.Figure 2Cross section 25 showing results from current drill program. Unlabelled holes are historical RC drill holes.Figure 3Cross section 27 showing results from current drill program. Unlabelled holes are historical RC drill holes.About AdytonMap showing the location of Adyton’s Papua New Guinea exploration projects relative to significant PNG gold projects.BRISBANE, Australia, June 11, 2021 (GLOBE NEWSWIRE) — Adyton Resources Corporation (TSX Venture: ADY) (“Adyton”) is pleased to report that multi-element analysis of drill core samples from the diamond drilling program at its 100% owned Gameta Gold Project have confirmed the potential for the...

Continue reading

Alm. Brand – Upgraded profit guidance for 2021

Announcement no. 12/2021 Upgraded profit guidance for 2021 As a result of a highly satisfactory and better-than-expected performance in the past few months, Alm. Brand upgrades its profit guidance for 2021 to DKK 700-750 million from the previous guidance of a profit of DKK 650-700 million. For Non-life Insurance, the guidance is lifted by DKK 100 million to a profit of DKK 725 million before tax, driven by a generally favourable trend in underlying insurance operations. However, growth has not materialised quite as soon after the reopening of society as had been expected, resulting in growth expectations of 1.5-2.0% for the full year, with continued focus on generating profitable growth. The guidance for Life Insurance is unchanged at a pre-tax profit of DKK 100 million and growth in regular premium payments of 3-4%. The guidance for...

Continue reading

Verkkokauppa.com Oyj – Managers’ Transactions – Seppälä

Verkkokauppa.com Oyj                MANAGERS’ TRANSACTIONS                June 11, 2021 at 14:00 EET Verkkokauppa.com Oyj has received a notification from Samuli Seppälä, Verkkokauppa.com Oyj’s Board member, of a transaction made with Verkkokauppa.com Oyj’s financial instrument, according to the Article 19 of EU Market Abuse Regulation. Detailed information about the transaction is given here under.Person subject to the notification requirementName: Seppälä, SamuliPosition: Member of the Board____________________________________________ Issuer: Verkkokauppa.com OyjLEI: 743700QZE6B52SHHTV75 Notification type: INITIAL NOTIFICATIONReference number: 743700QZE6B52SHHTV75_20210611102949_4____________________________________________ Transaction date: 10 June 2021Instrument type: SHAREISIN: FI4000049812Nature of the transaction: DISPOSAL Transaction...

Continue reading

Tinley’s Closes $2.4MM Private Placement to Advance Co-Packing Engagements and Product Distribution

LOS ANGELES and TORONTO, June 11, 2021 (GLOBE NEWSWIRE) — The Tinley Beverage Company (CSE:TNY, OTC:TNYBF) (“Tinley’s” or “Company”) is pleased to announce that it has closed a C$2.4 million private placement to advance its co-packing and branded product growth. Closing occurred on June 10, 2021. The Company continues to make capital investments to expand the scope of product formulation types and packaging formats that can be produced at its cannabis beverage manufacturing facility in Long Beach, California. The mini line and bottling lines have significant bookings in June and July, including third-party brands as well as manufacturing additional inventory of the Company’s own products to fulfill dispensary demand. The commissioning of the canning line is currently expected to be completed this month, with initial clients currently...

Continue reading

Theralase® Launches Seventh US-Based Clinical Study Site and Treats First Patient in the US

TORONTO, June 11, 2021 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of innovative Anti-Cancer Therapy (“ACT”) technologies intended to safely and effectively destroy various cancers, bacteria and viruses, while preserving patient Quality Of Life (“QOL”) announced today the launch of the seventh US-based Clinical Study Site (“CSS”); specifically, the University of Chicago Medicine (“UChicago Medicine”). UChicago Medicine has successfully received Institutional Review Board (“IRB”) approval allowing them to commence enrollment and treatment of patients in Theralase®’s pivotal Phase II Non-Muscle Invasive Bladder Cancer (“NMIBC“) Clinical Study (“Study II”). Study II is focused...

Continue reading

Alm. Brand A/S to acquire the Danish business of Codan Forsikring A/S

Company announcement no. 11/2021 Alm. Brand A/S to acquire the Danish business of Codan Forsikring A/S Alm. Brand A/S (“Alm. Brand”) is pleased to announce that it has entered into a binding agreement with Intact Financial Corporation (“Intact”) and Tryg A/S (“Tryg”), through their jointly-owned subsidiary Scandi JV Co 2 A/S (“Seller“), whereby Alm. Brand will acquire Codan Forsikring A/S’s (“Codan Forsikring”) Danish business (the “Acquisition”). The Acquisition is currently expected to complete during the first half of 2022 following the transfer by Intact and Tryg of the Danish business of Codan Forsikring into a Danish legal entity incorporated for such purpose (“Codan DK”). Chairman of the Board of Directors Jørgen Hesselbjerg Mikkelsen:“With the acquisition of Codan DK, the Board of Directors sets a clear strategic course,...

Continue reading

Sinch AB (publ): Share split in Sinch AB (publ)

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCH On 18 May 2021, the annual general meeting in Sinch AB (publ) resolved on a share split 10:1 whereby each share is divided into ten shares. The board of directors was authorized to determine the record date for the split of the company’s shares. The board of directors has determined that the record date for the split of the shares in Sinch AB (publ) will be 18 June 2021. The last day of trading in the company’s shares before the share split is 16 June 2021. The first day of trading in the company’s shares after the share split is 17 June 2021. Following the share split, the new ISIN code for the company’s shares will be SE0016101844. After the share split is completed, the number of shares in the company will increase from 72,267,211 shares to 722,672,110 shares and the quota value of...

Continue reading

Code Red, a GameSquare Esports Company, Awarded U.S. Polo Assn. Contract

TORONTO, June 11, 2021 (GLOBE NEWSWIRE) — GameSquare Esports Inc. (CSE: GSQ; FRA: 29Q1) (“GameSquare”, “GameSquare Esports” or the “Company”), an international gaming and esports company, is pleased to announce that its subsidiary, Code Red Esports Ltd. (“Code Red”), The Authentic Esports Agency, has been awarded a contract to provide esports consultancy services to U.S. Polo Assn., the official brand of the United States Polo Association (“USPA”). U.S. Polo Assn. offers apparel for men, women and children, as well as accessories, footwear, travel and home goods in 180 countries worldwide. Recently ranked the fifth largest sports licensor in License Global magazine’s 2020 list of “Top 150 Global Licensors,” U.S. Polo Assn. is named alongside such iconic sports brands as the National Football League, the National...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.